- Home
- MDCX vs NTIP Comparison
MDCX vs NTIP Comparison
Compare MDCX & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDCX
- NTIP
- Stock Information
- Founded
- MDCX 2008
- NTIP 1990
- Country
- MDCX Canada
- NTIP United States
- Employees
- MDCX N/A
- NTIP N/A
- Industry
- MDCX
- NTIP Multi-Sector Companies
- Sector
- MDCX
- NTIP Miscellaneous
- Exchange
- MDCX Nasdaq
- NTIP Nasdaq
- Market Cap
- MDCX 44.0M
- NTIP 28.6M
- IPO Year
- MDCX N/A
- NTIP 1998
- Fundamental
- Price
- MDCX $3.22
- NTIP $1.24
- Analyst Decision
- MDCX Strong Buy
- NTIP
- Analyst Count
- MDCX 2
- NTIP 0
- Target Price
- MDCX $23.50
- NTIP N/A
- AVG Volume (30 Days)
- MDCX 281.1K
- NTIP 13.5K
- Earning Date
- MDCX 08-22-2025
- NTIP 08-11-2025
- Dividend Yield
- MDCX N/A
- NTIP 8.00%
- EPS Growth
- MDCX N/A
- NTIP N/A
- EPS
- MDCX N/A
- NTIP N/A
- Revenue
- MDCX N/A
- NTIP $250,000.00
- Revenue This Year
- MDCX N/A
- NTIP N/A
- Revenue Next Year
- MDCX N/A
- NTIP N/A
- P/E Ratio
- MDCX N/A
- NTIP N/A
- Revenue Growth
- MDCX N/A
- NTIP N/A
- 52 Week Low
- MDCX $1.80
- NTIP $1.16
- 52 Week High
- MDCX $8.94
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- MDCX N/A
- NTIP 50.22
- Support Level
- MDCX N/A
- NTIP $1.16
- Resistance Level
- MDCX N/A
- NTIP $1.30
- Average True Range (ATR)
- MDCX 0.00
- NTIP 0.05
- MACD
- MDCX 0.00
- NTIP -0.00
- Stochastic Oscillator
- MDCX 0.00
- NTIP 57.14
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.